Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol

被引：0
|
作者：
Dennis Schrijnders
Geertruida H. de Bock
Sebastiaan T. Houweling
Kornelis J. J. van Hateren
Klaas H. Groenier
Jeffrey A. Johnson
Henk J. G. Bilo
Nanne Kleefstra
Gijs W. D. Landman
机构：
[1] Isala,Diabetes Centre
[2] Langerhans Medical Research Group,Department of Epidemiology
[3] University of Groningen,Department of General Practice
[4] University Medical Center Groningen,Department of Internal Medicine
[5] University of Groningen,Department of Internal Medicine
[6] University Medical Center Groningen,Department of Internal Medicine
[7] School of Public Health,undefined
[8] University of Alberta,undefined
[9] University of Groningen,undefined
[10] University Medical Center Groningen,undefined
[11] Isala,undefined
[12] Gelre Hospital,undefined
来源：
BMC Cancer | / 17卷
关键词：
Type 2 diabetes; Sulfonylureas; Cancer; Within-class differences;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The Relationship between Obesity and Cancer Mortality in Type 2 Diabetes: A Ten-year Follow-up Study (ZODIAC-21)
    Landman, G. W.
    Van Hateren, K. J. J.
    Kleefstra, N.
    Bilo, H. J. G.
    ANTICANCER RESEARCH, 2010, 30 (02) : 681 - 682
  • [22] Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients
    Lo, Sui-Foon
    Chang, Shih-Ni
    Muo, Chih-Hsin
    Chen, Shih-Yin
    Liao, Fang-Yin
    Dee, Shu-Wei
    Chen, Pei-Chun
    Sung, Fung-Chang
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (01) : 182 - 188
  • [23] Association Between Statins and Cancer Incidence in Diabetes: a Cohort Study of Japanese Patients with Type 2 Diabetes
    Sadanori Okada
    Takeshi Morimoto
    Hisao Ogawa
    Hirofumi Soejima
    Chisa Matsumoto
    Mio Sakuma
    Masafumi Nakayama
    Naofumi Doi
    Hideaki Jinnouchi
    Masako Waki
    Izuru Masuda
    Yoshihiko Saito
    Journal of General Internal Medicine, 2021, 36 : 632 - 639
  • [24] Incident Cancer Risk in Patients with Incident Type 2 Diabetes Mellitus in Hungary (Part 1)
    Abonyi-Toth, Zsolt
    Rokszin, Gyoergy
    Fabian, Ibolya
    Kiss, Zoltan
    Jermendy, Gyoergy
    Kempler, Peter
    Lengyel, Csaba
    Wittmann, Istvan
    Molnar, Gergo A.
    Suto, Gabor
    CANCERS, 2024, 16 (09)
  • [25] Is Vitamin D Deficiency Related to Increased Cancer Risk in Patients with Type 2 Diabetes Mellitus?
    Gabryanczyk, Anna
    Klimczak, Sylwia
    Szymczak-Pajor, Izabela
    Sliwinska, Agnieszka
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [26] Glycated hemoglobin, diabetes treatment and cancer risk in type 2 diabetes. A case-control study
    Dabrowski, Mariusz
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2013, 20 (01) : 116 - 121
  • [27] Association Between Statins and Cancer Incidence in Diabetes: a Cohort Study of Japanese Patients with Type 2 Diabetes
    Okada, Sadanori
    Morimoto, Takeshi
    Ogawa, Hisao
    Soejima, Hirofumi
    Matsumoto, Chisa
    Sakuma, Mio
    Nakayama, Masafumi
    Doi, Naofumi
    Jinnouchi, Hideaki
    Waki, Masako
    Masuda, Izuru
    Saito, Yoshihiko
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (03) : 632 - 639
  • [28] Risk factors for cancer development in type 2 diabetes: A retrospective case-control study
    Mariusz Dąbrowski
    Elektra Szymańska-Garbacz
    Zofia Miszczyszyn
    Tadeusz Dereziński
    Leszek Czupryniak
    BMC Cancer, 16
  • [29] Study of the Association Between Antihyperglycemic Therapy and Cancer in Patients with Type 2 Diabetes Mellitus
    Vatseba, Tamara
    Sokolova, Liubov
    Pushkarev, Volodymyr
    Koshel, Nataliia
    GALICIAN MEDICAL JOURNAL, 2020, 27 (03)
  • [30] Risk factors for cancer development in type 2 diabetes: A retrospective case-control study
    Dabrowski, Mariusz
    Szymanska-Garbacz, Elektra
    Miszczyszyn, Zofia
    Derezinski, Tadeusz
    Czupryniak, Leszek
    BMC CANCER, 2016, 16
12345